GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (XCNQ:RVV) » Definitions » Research & Development

Revive Therapeutics (XCNQ:RVV) Research & Development : C$0.57 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Revive Therapeutics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Revive Therapeutics's Research & Development for the three months ended in Dec. 2023 was C$0.43 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.57 Mil.

Revive Therapeutics Research & Development Historical Data

The historical data trend for Revive Therapeutics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics Research & Development Chart

Revive Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.46 6.71 15.16 3.58

Revive Therapeutics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.16 1.24 - 0.13 0.43

Revive Therapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revive Therapeutics  (XCNQ:RVV) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Revive Therapeutics Research & Development Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Revive Therapeutics (XCNQ:RVV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (XCNQ:RVV) » Definitions » Research & Development
Comparable Companies
TSX:WLLW XCNQ:SLNG TSXV:NDVA XCNQ:IMCC TSX:CTX XCNQ:STHZ XCNQ:OILS XCNQ:XTRX TSX:VPH XCNQ:CANN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
RVVTF:USA 31R:Germany
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Website
https://www.revivethera.com
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.
Executives
Michael Frank Director, Senior Officer

Revive Therapeutics (XCNQ:RVV) Headlines

No Headlines